Prot #ALN-TTR02-012: A Phase 4 Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients with Polyneuropathy of Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with a V122I or T60A Mutation

Project: Research project

Project Details

StatusActive
Effective start/end date6/29/206/29/23

Funding

  • Quintiles, Inc. (Prot #ALN-TTR02-012)
  • Alnylam Pharmaceuticals, Inc. (Prot #ALN-TTR02-012)